Thromb Haemost 2009; 102(04): 620-622
DOI: 10.1160/TH09-06-0346
Rapid and Short Communication
Schattauer GmbH

Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years

Karen Koopman
1   Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands
,
Maarten Uyttenboogaart
1   Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands
,
Patrick C. A. J. Vroomen
1   Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands
,
Jan van der Meer*
2   Department of Haematology, University Medical Centre Groningen, University of Groningen, The Netherlands
,
Jacques De Keyser
1   Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands
3   Department of Neurology, Universitair Ziekenhuis Brussel, Vrije Universiteit, Brussel, Belgium
,
Gert-Jan Luijckx
1   Department of Neurology, University Medical Centre Groningen, University of Groningen, The Netherlands
› Author Affiliations
Further Information

Publication History

Received: 02 July 2009

Accepted after major revision: 02 August 2009

Publication Date:
24 November 2017 (online)

Summary

Cerebral venous thrombosis (CVT) and deep vein thrombosis or pulmonary embolism (DVT/PE) are associated with many risk factors. It is unclear why CVT occurs less often than DVT/PE. Age dependent risk factors may play a role. The aim of our study was to compare risk factors in a uniform age group of CVT and DVT/PE patients aged between 15 and 50 years. Thrombophilic markers and clinical risk factors of 79 CVT patients and 173 DVT/PE patients aged 15–50 years were compared. Multivariable logistic regression analysis was performed to investigate if risk factors were independently associated with CVT or DVT/ PE. Cerebral venous thrombosis patients were younger (median age 30 years vs. 42 years; p<0.001) and more often female (82% vs. 52%; p<0.001). There were no differences in thrombophilic markers. Cerebral venous thrombosis was less often associated with trauma, immobilisation or surgery than DVT/PE (6% vs. 21%; adjusted OR 0.29; 95%CI 0.10–0.82). In women, CVT was more frequently associated with oral contraceptive use, pregnancy or puerperium (82% vs. 53%; adjusted OR 2.34; 95%CI 1.03–5.32).This study demonstrated no differences in thrombophilic markers between CVT patients and DVT/PE patients aged between 15 and 50 years, while the frequency of some transient risk factors was different. Cerebral venous thrombosis was relatively more common in women and hormonal factors may predispose to CVT compared to DVT/PE, while trauma, immobilisation and surgery may be less important in the pathophysiology of CVT.

* Deceased January 14, 2009.


 
  • References

  • 1 Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 06: 162-170.
  • 2 Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352: 1791-1798.
  • 3 Spencer FA, Gore JM, Lessard D. et al. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost 2008; 100: 780-788.
  • 4 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
  • 5 Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002; 70: 126-132.
  • 6 Libourel EJ, ten MKKate, Brouwer JL, Veeger NJ, van der Meer J. Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis. Thromb Res 2007; 121: 301-307.
  • 7 Wysokinska EM, Wysokinski WE, Brown RD. et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 2008; 70: 627-633.
  • 8 Koopman K, Uyttenboogaart M, Vroomen PC, van der Meer J, De Keyser J, Luijckx GJ. Development and validation of a predictive outcome score of cerebral venous thrombosis. J Neurol Sci 2009; 276: 66-68.
  • 9 Bousser MG, Russell RR. Cerebral venous thrombosis. In: Warlow CP, Van Gijn J. eds. Major Problems in Neurology. London, UK: WB Saunders; 1997: 27-29.
  • 10 Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med 2006; 145: 807-815.
  • 11 Blanco-Molina A, Trujillo-Santos J, Tirado R. et al. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb Haemost 2009; 101: 478-482.
  • 12 Rosenberg RD, Aird WC. Vascular-bed--specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 1555-1564.
  • 13 Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-1797.
  • 14 Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
  • 15 Coutinho JM, Ferro JM, Canhao P. et al. Cerebral venous and sinus thrombosis in women. Stroke 2009; 40: 2356-2361.
  • 16 Samama M, Gerotziafas G, Conard J, Horellou M, Elalamy I. Clinical aspects and laboratory problems in hereditary thrombophilia. Haemostasis 1999; 29: 76-99.